Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
A large, matched cohort study using U.S. Veterans Health Administration data found that patients with gout are significantly more likely to receive chronic opioid prescriptions than those without gout—particularly among underserved...
A large, matched cohort study using U.S. Veterans Health Administration data found that patients with gout are significantly more likely to receive chronic opioid prescriptions than those without gout—particularly among underserved...
For rheumatologists, these findings suggest that monthly dosing of pegloticase with MTX may offer a more patient-friendly regimen without compromising therapeutic outcomes, particularly for those with uncontrolled gout requiring long-term...
For rheumatologists, these findings suggest that monthly dosing of pegloticase with MTX may offer a more patient-friendly regimen without compromising therapeutic outcomes, particularly for those with uncontrolled gout requiring long-term...
Given the known cardiovascular burden among patients with gout, these findings may prompt changes in prophylaxis prescribing practices to prioritize long-term cardiovascular safety.
Given the known cardiovascular burden among patients with gout, these findings may prompt changes in prophylaxis prescribing practices to prioritize long-term cardiovascular safety.
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
A composite measure of disease activity in axial spondyloarthritis that includes extra-articular manifestations could provide more accurate assessments, researchers say.
A composite measure of disease activity in axial spondyloarthritis that includes extra-articular manifestations could provide more accurate assessments, researchers say.
Researchers investigated whether using antiobesity medications, and the pace of weight loss, reduced mortality among patients with overweight or obesity and knee or hip osteoarthritis.
Researchers investigated whether using antiobesity medications, and the pace of weight loss, reduced mortality among patients with overweight or obesity and knee or hip osteoarthritis.